Internal Server Error

About Foresite Capital

Foresite Capital is a venture capital firm founded in 2011. It is primarily based out of New York City, United States. As of Sep 2026, Foresite Capital is an active investor, having invested in 215 companies, with 10 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Post IPO round of Korsana Overall, Foresite Capital portfolio has seen 7 unicorns, 87 IPOs and 69 acquisitions including key companies like Hims, Natera and GRAIL. A lot of funds co-invest with Foresite Capital, with names like Orbimed sharing a substantial percentage of its portfolio. Foresite Capital has team of 19 people including 10 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series C & 7 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months

Foresite Capital's List of Top Investments

Foresite Capital has a portfolio of 215 companies, including 7 unicorns. Their most notable investments are in Element Biosciences and Pharvaris.Their portfolio spans across United States, United Kingdom, Canada and 6 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 7 other sectors, across stages such as Series B, Series C  and 7 more. Here is the list of top investments by Foresite Capital:

1. Hims

Online platform offering telehealth services for men's wellness. The company focuses on men's wellness and care, offering treatment options for hair loss, erectile dysfunction, and more.

Key facts about Hims

Developer of cell-free DNA testing for oncology, women’s health, and organ health. The test provided by the company inlcude Signatera– a residual disease test (MRD), Altera– tumor genomic profile, Empower– Hereditary cancer test, Prospera Kidney– transplant assessment, Panorama– Noninvasive prenatal testing (NIPT), Anora– Miscarriage Test, and more.

Key facts about Natera

Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.

Key facts about GRAIL

  • Founded Year: 2016
  • Location: Menlo Park (United States)
  • Annual Revenue: $100M - $500M as on Dec 31, 2025
  • Stage: Public
  • Total Funding till date: $2B
  • Employee Count: 1,141 as on Sep 30, 2026
  • Investors: Foresite Capital, Gershon Capital and 52 Others
  • Latest Funding Round: Post IPO, Jun 25, 2026, $*****
  • Highlight: Public
Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis. The company develops instruments, consumables, and software that enable researchers to profile up to a million cells, map RNA and proteins in tissues, and support multiomics workflows, with products cited in publications.

Key facts about 10X Genomics

Provider of cloud-based cardiac rhythm monitoring devices. It provides Zio ambulatory ECG monitor a wearable patch designed to gather beat-to-beat heart data for the diagnosis of cardiac arrhythmias. The device stores data in the patch and is emailed to the iRhythm cloud at the end of the monitoring period. myZio iPhone app is an add-on for the Zio Patch for physicians to make a diagnosis.

Key facts about iRhythm Tech

Foresite Capital's Investments by Stage

Foresite Capital has made 43 investments in Series B stage with an average round size of $65.2M, 26 investments in Series C stage with an average round size of $115M and 24 investments in Series A stage with an average round size of $87.9M.
Here are Foresite Capital's investments by stage:
Stage of entry
No. of Investments
Series B
42
Series C
26
Series A
24
Post IPO
10
Series D
8
Others
9
Breakdown of Foresite Capital's investments by stage of entrySeries B (42)Series C (26)
Note: We have considered here, only first round of investments

Foresite Capital's Investments by Sector

Foresite Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Enterprise Applications and Sustainability Tech. Notably, it has invested in 194 Tech companies, 184 Enterprise (B2B) companies, 32 Software companies and at least 18 companies focusing on Tech hardware.
Here are Foresite Capital's investments by sector:
Sector
No. of Investments
Life Sciences
102
High Tech
26
HealthTech
19
Enterprise Applications
15
Sustainability Tech
7
Others
16
Breakdown of Foresite Capital's investments by sectorsLife Sciences (102)High Tech (26)
Note: We have considered here, only first round of investments

Foresite Capital's Investments by Geography

Foresite Capital has made most investments in United States (107), followed by United Kingdom where it has made 6 investments.
Here are Foresite Capital's investments by geography:
Country
No. of Investments
United States
107
United Kingdom
6
Ireland
2
China
1
Israel
1
Others
1
Breakdown of Foresite Capital's investments by countriesUnited States (107)United Kingdom (6)
Note: We have considered here, only first round of investments

Foresite Capital's recent investments

Foresite Capital has made 12 investments in 2026 so far. Korsana and Thyme Care are the latest among them.
Here are the most recent investments by Foresite Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Sep 10, 2026
United States
Post IPO
4457
Sep 02, 2026
United States
Series E
8945
Aug 13, 2026
United States
Series B
5415
Aug 07, 2026
United States
Series D
5699
Aug 05, 2026
United States
Post IPO
6757

Unicorns in Foresite Capital's Portfolio

Foresite Capital has 7 unicorns in its portfolio - Join Midi, Thyme Care, Element Biosciences and others. The most recent unicorn in their portfolio is Join Midi. It became a unicorn in 2026.
Here is a list of unicorns in Foresite Capital's portfolio:
Tracxn Score
Company
Short Description
Founded year
Sector
Location
Company Stage
First Investment/ Acquisition Details
67
Provider of a virtual care platform focused on female midlife health
2021
Los Altos Hills
Series D
pleqjhj
68
Provider of home nursing care services
2020
Nashville
Series E
vgbezhq
64
Developer of benchtop DNA sequencer for research applications
2017
San Diego
Series E
vassddr
64
Provider of molecular diagnostics platform by using CRISPR technology
2017
Brisbane
Series D
b{sszaw
60
Provider of home-based diagnostic tests for the detection of various diseases
2014
Austin
Funding Raised
wyxgwyb

IPOs and Publicly Listed companies in Foresite Capital's Portfolio

87 of Foresite Capital's portfolio companies have become public. Korsana got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Sep 2026 and Latigo Biotherapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $1.14B.
Here are Foresite Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Sep 09, 2026
Feb 18, 2026
Series A
9068
Aug 07, 2026
Feb 14, 2024
Series A
9003
Aug 04, 2026
Apr 03, 2024
Series C
7149
Jun 10, 2026
Mar 01, 2024
Series E
8669
May 08, 2026
Dec 08, 2021
Series A
6727

Acquired companies in Foresite Capital's Portfolio

69 companies from Foresite Capital's portfolio have been acquired. The most recent acquisition was Kira Pharmaceuticals in Jul 2026 by Jasper Therapeutics for $*****.
Here are Foresite Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jul 16, 2026
Jan 07, 2021
Series B
7294
Jun 17, 2026
Apr 04, 2025
Series A
5846
May 03, 2026
Sep 09, 2024
Series D
9084
Jan 20, 2026
Dec 23, 2024
Post IPO
3222
Dec 15, 2025
Feb 27, 2018
Series B
4414

Team profile of Foresite Capital

Foresite Capital has a team of 19 members including 10 Partners located in United States. Foresite Capital's team sits on the board of 2 companies.
Here is a list of top team members in Foresite Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
-
Partner
San Francisco
Partner
Denver
-
Partner
San Francisco
-
Partner
New York City
-
Partner
San Francisco
-
Partner
New York City
-
Partner
Denver
-
Partner
-
-
Partner
-
-

Co-investors of Foresite Capital

Over the past 14 years, 923 investors have co-invested in Foresite Capital's portfolio companies. This includes funds and angels.

  • Invested before Foresite Capital: HHS, Google Ventures and 364 others have invested in rounds before Foresite Capital. There are 14 companies where HHS has invested before Foresite Capital and 11 companies where Google Ventures has invested before Foresite Capital.
  • Top Co-investors of Foresite Capital: 264 investors entered a company along with Foresite Capital. These include investors like Orbimed (19 companies).
  • Invested after Foresite Capital: A total of 293 investors have invested in Foresite Capital's portfolio after their investments. Top Investors include RA Capital Management (9 companies), Fidelity Investments (8 companies) and Janus Henderson Investors (8 companies).

Recent News related to Foresite Capital

•
KymaThera Raises $80M Series B FundingFinSMEs•Oct 06, 2026•KymaThera, Alta Partners, Venrock, Foresite Capital and 1 other
•
Pinnacle raises an $89M series B for its oral peptide programsBioWorld•Mar 26, 2026•Pinnacle Medicines, LAV, Foresite Capital, Logos and 4 others
View all news related to Foresite Capital

FAQs about Foresite Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford